Suppression Risks of S‑23 vs LGD‑4033

S-23 doesn't play nice. This compound crushes your natural testosterone production far harder than LGD-4033, often shutting it down almost completely in just 2–3 weeks, while LGD only trims 40–60% over 4–6 weeks. Its high binding affinity smashes luteinizing hormone, making immediate PCT essential and locking you into a 4–8 week recovery.

LGD-4033, on the other hand, lets your hormones keep ticking, so recovery is faster, usually around 4–6 weeks. Knowing how these compounds work can save you headaches and help you plan your cycles smarter, not harder.

Suppression Severity and Timeline Differences​

When comparing S-23 and LGD-4033, you'll find that S-23 typically causes more severe suppression within a shorter timeframe due to its higher binding affinity and more aggressive interaction with androgen receptors.

S-23 can considerably suppress testosterone production within 2-3 weeks, often requiring immediate PCT intervention. LGD-4033, while still suppressive, generally shows milder effects that develop more gradually over 4-6 weeks.

Your natural testosterone recovery also differs between compounds. S-23 users often experience longer recovery periods of 4-8 weeks post-cycle, while LGD-4033 users typically see baseline restoration within 2-4 weeks. The severity depends heavily on dosage and cycle length, but S-23's potent nature makes it inherently riskier for maintaining hormonal balance throughout your cycle.

Why S-23 Shuts Down Testosterone Production More Aggressively​

Although both compounds target androgen receptors, S-23's molecular structure creates a more potent suppressive effect through its exceptionally high binding affinity and partial agonist activity.

You'll experience more severe testosterone shutdown with S-23 because it binds to androgen receptors with nearly the same strength as DHT, causing your hypothalamus to detect high androgen levels and drastically reduce luteinizing hormone production. This cascade effect fundamentally tells your testes to stop producing testosterone.

LGD-4033's weaker binding affinity means it doesn't trigger the same aggressive suppression response. While LGD can still reduce your natural testosterone, S-23's powerful receptor activation creates a more complete shutdown of your hypothalamic-pituitary-gonadal axis, often requiring longer recovery periods and more intensive post-cycle therapy protocols.

LGD-4033's Milder Impact on Natural Hormone Levels​

While S-23 creates aggressive testosterone suppression, LGD-4033's selective receptor binding produces a more manageable hormonal impact that doesn't completely shut down your natural production. Studies show LGD-4033 causes moderate suppression, typically reducing testosterone levels by 40-60% rather than the near-complete shutdown seen with S-23.

Your hypothalamic-pituitary-gonadal axis remains partially functional during LGD-4033 cycles, meaning you'll retain some natural hormone production. This selective modulation occurs because LGD-4033's binding affinity, while potent, doesn't trigger the same degree of negative feedback that more aggressive compounds produce.

Recovery timelines reflect this milder impact. Most users experience testosterone normalization within 4-6 weeks post-cycle without PCT, compared to S-23's potentially months-long recovery period requiring pharmaceutical intervention.

How Dosage and Cycle Length Affect Your Suppression Risk​

Since both compounds follow dose-dependent suppression patterns, your risk escalates markedly as you push beyond conservative dosages and extend cycle lengths past recommended timeframes.

S-23 at 10-20mg daily for 6-8 weeks creates moderate suppression, while 30mg+ for 12+ weeks often triggers severe shutdown requiring aggressive PCT. LGD-4033 shows milder suppression at 5-10mg for 8 weeks, but 20mg+ doses or 12+ week cycles substantially increase your risk.

Your HPG axis becomes increasingly resistant to recovery as exposure duration extends. Eight-week cycles typically allow natural rebound within 4-6 weeks, while 12+ week cycles may require 8-12 weeks of recovery time.

Conservative dosing preserves your body's ability to restore baseline testosterone levels efficiently, reducing dependency on pharmaceutical intervention.

Recovery Time and PCT Requirements for Each SARM​

Because S-23 creates more profound suppression than LGD-4033, your recovery protocols must reflect these differences in severity and duration.

For S-23 cycles, you'll typically need 6-12 weeks for natural testosterone recovery without PCT, though some users require longer. LGD-4033 generally allows faster recovery, often 4-8 weeks naturally.

PCT becomes essential for S-23 cycles exceeding 6 weeks or higher doses. Take SERMs like tamoxifen or clomiphene for 4-6 weeks post-cycle. LGD-4033 may not require PCT for shorter, lower-dose cycles, but experts recommend it for cycles over 8 weeks.

Monitor your recovery through bloodwork at weeks 4, 8, and 12 post-cycle. Look for testosterone, LH, and FSH normalization. If levels remain suppressed beyond expected timeframes, extend your recovery period and consider medical consultation.